Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menopausal Hormone Therapy for Women Living with HIV
PACTR202606566079040Phase 4Recruiting
- Sponsor
- National Institutes of Health
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in vasomotor symptoms comparing Estradiol gel plus oral micronized progesterone with Matching placebo (2 arms). Primary endpoint: Change in mean vasomotor symptom frequency. Started Mar 2026; status: recruiting.
02
Drugs
estradiolprogesterone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on PACTR202606566079040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606566079040.